Search

Your search keyword '"Guilleminault, Laurent"' showing total 290 results

Search Constraints

Start Over You searched for: Author "Guilleminault, Laurent" Remove constraint Author: "Guilleminault, Laurent"
290 results on '"Guilleminault, Laurent"'

Search Results

2. Anti–IL-4R versus anti–IL-5/5R after anti–IL-5/5R failure in asthma: An emulated target trial

4. Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study

5. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

7. Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19

8. Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry

9. Guidelines for the management of chronic cough in adults. Endorsed by the French speaking society of respiratory diseases (Société de Pneumologie de Langue Française, SPLF), the Société Française d'Oto-Rhino-Laryngologie et de Chirurgie de la Face et du Cou (SFORL), the Société Française de Phoniatrie et de Laryngologie (SFPL), the Société Nationale Française de Gastro-entérologie (SNFGE)

12. Updated guidelines (2021) for management and follow-up of asthmatic patients of the French Society of Pneumology (SPLF) and the French Society of Pediatric Pneumology and Allergology (SP2A). Short version

18. Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial

24. Towards an artificial intelligence-assisted allergy diagnosis using semantic attributes and allergen multiplex technology

25. Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice

26. Obesity Predicts Treatment Response to Proton Pump Inhibitor Therapy in Patients with Chronic Cough

31. Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi study

32. Improvement of exertional dyspneoa in patients with chronic obstructive pulmonary disease and severe allergic asthma responding to omalizumab

34. Characteristics of severe asthma patients included in the French Palomb Cohort.

36. Is refractory chronic cough a genetic disease?

37. Clinical and biological characteristics associated with bronchial or pulmonary abnormalities on chest CT imaging in patients with systemic mastocytosis.

38. Association of country income level with the characteristics and outcomes of critically ill patients hospitalized with acute kidney injury and COVID-19

40. Benralizumab for eosinophilic granulomatosis with polyangiitis

41. Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry

42. Digital Action Plan (Web App) for Managing Asthma Exacerbations: Randomized Controlled Trial

47. Repeat Expansions of RFC1 in Refractory Chronic Cough

48. NOVEOS (Hycor) demonstrates better clinical performance than ImmunoCAP™ (Thermofisher) for food allergy diagnosis

49. Sputum-Rheology-Based Strategy for Guiding Azithromycin Prescription in COPD Patients with Frequent Exacerbations: A Randomized, Controlled Study (“COPD CARhE”)

50. Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin

Catalog

Books, media, physical & digital resources